转移性HER2阳性乳腺癌:是否有最佳的治疗顺序?
Naomi Dempsey1, Ana Sandoval1, Reshma Mahtani2
1Miami Cancer Institute, 8900 Kendall Drive, Miami, FL, USA.
Current treatment options in oncology
|July 10, 2023
概括
对HER2阳性转移性乳腺癌 (MBC) 的治疗已经进步,现在已经建立了特定的第一线,第二线和第三线疗法. 目前正在进行的研究正在探索新的治疗方法和生物标志物,以优化在先进的HER2+MBC中的护理.
科学领域:
- 在瘤学瘤学.
- 医学治疗学 医学治疗学
- 临床研究 临床研究
背景情况:
- 大约20%的乳腺癌过度表达人体表皮生长因子受体2 (HER2+),代表了攻击性的亚型.
- 从历史上看,HER2+诊断由于系统性和大脑转移的高风险,导致预后不佳.
- 针对HER2的治疗方法的进步显著改善了结果,改变了预后.
研究的目的:
- 为 HER2 阳性晚期乳腺癌提供当前和未来的管理策略的概述.
- 针对特定场景的治疗选择,包括三重阳性乳腺癌和大脑转移.
- 突出有前途的新型治疗方法和正在进行的试验,影响未来的治疗顺序.
主要方法:
- 对HER2+转移性乳腺癌 (MBC) 的当前标准护理一线,二线和三线治疗方法的审查.
- 讨论第四线和超越设置的治疗选择.
- 探索正在研究的新疗法及其潜在影响.
主要成果:
- 一线标准:塔克森 + 特拉斯图祖马布 + 珀图祖马布.
- 二线偏好:特拉斯图祖马布德鲁克斯泰坎 (除了中枢神经系统的参与,其中可以考虑图卡提尼布+卡佩西塔+特拉斯图祖马布).
- 第三线偏好:由于证明了生存益处,图卡提尼布治疗方案.
结论:
- 对于HER2+高级乳腺癌的治疗环境是动态的,治疗方法转向早期阶段.
- 识别生物标志物和耐药机制对于优化治疗选择和患者结果至关重要.
- 未来的管理将由新的治疗方法和正在进行的临床试验来塑造,强调个性化的方法.
关键词:
市场上有很多可能.转移性HER2阳性乳腺癌尼拉丁尼布 (Neratinib) 是一种有毒的药物.皮尔图祖马布 (Pertuzumab) 是一种药物.这就是Trastuzumab.特拉斯图祖马布可以脱.特拉斯图祖马布 (Trastuzumab) 是一种素.图卡替尼布 (Tucatinib) 是一种更多相关视频
10:01Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
6.7K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K